Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Histological and Endoscopic Evaluation of Remission Induced by Infliximab in Moderately to Severely Active Ulcerative Colitis Patients

NCT01408810 is registered in ClinicalTrials.gov with Grupo de Estudo da Doença Inflamatória Intestinal as lead sponsor.

NCT NCT01408810
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01408810 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Histological and Endoscopic Evaluation of Remission Induced by Infliximab in Moderately to Severely Active Ulcerative Colitis Patients
Lead sponsor
Grupo de Estudo da Doença Inflamatória Intestinal
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2011
Completion date
November 30, 2012
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis